Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV001118410 | SCV001276688 | uncertain significance | Saldino-Mainzer syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Labcorp Genetics |
RCV001118410 | SCV002305260 | uncertain significance | Saldino-Mainzer syndrome | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with threonine at codon 437 of the IFT140 protein (p.Ala437Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs373106880, ExAC 0.009%). This variant has not been reported in the literature in individuals with IFT140-related conditions. ClinVar contains an entry for this variant (Variation ID: 886296). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Fulgent Genetics, |
RCV002497529 | SCV002812740 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-04-17 | criteria provided, single submitter | clinical testing | |
| Dept Of Ophthalmology, |
RCV003890262 | SCV004705020 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
| Ambry Genetics | RCV004629457 | SCV005121074 | likely benign | Inborn genetic diseases | 2024-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |